Quick Answer
Guardian Pharmacy Services, Inc. reported Cash and Equivalents of $65.62 million for fiscal year 2025.
Guardian Pharmacy Services, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $65.62M | +1308.1% |
| 2024 | $4.66M | +519.7% |
| 2023 | $752.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.49M | -2.0% | +93.9% |
| June 30, 2025 | $18.82M | — | +34.4% |
| March 31, 2025 | $14.00M | — | +200.4% |
| December 31, 2024 | $4.66M | +519.7% | -87.5% |
| September 30, 2024 | $37.22M | — | +4849.6% |
| December 31, 2023 | $752.0K | — | — |
- Guardian Pharmacy Services, Inc. showed an increase of +1308.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Guardian Pharmacy Services, Inc.’s cash and equivalents has grown by 8625.9% (from $752.0 thousand to $65.62 million).
- The most recent figure is from Guardian Pharmacy Services, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: